SABS - SAB Biotherapeutics, Inc.
IEX Last Trade
4.19
0 0%
Share volume: 134
Last Updated: Thu 26 Dec 2024 05:56:41 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$4.19
0.00
0.00%
Summary score
8%
Profitability
0%
Dept financing
10%
Liquidity
53%
Performance
5%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-22.98%
Return on assets
-16.02%
Return on sales
-1933.56%
Return on invested capital
-50.59%
Total debt ratio
38.65%
Debt ratio change over timeo
-1.09%
Current Ratio
2.2%
Quick Ratio
2.2%
Cash Position Ratio
1.8%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-29.44%
Return on assets
-18.88%
Return on sales
-3846.8%
Return on invested capital
-67.1%
Total debt ratio
37.07%
Debt ratio change over timeo
-0.12%
Current Ratio
3.06%
Quick Ratio
3.06%
Cash Position Ratio
2.88%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-9.51%
Return on assets
-15.96%
Return on sales
-1205.9%
Return on invested capital
-31.19%
Total debt ratio
25.99%
Debt ratio change over time
-1.16%
Current Ratio
5.65%
Quick Ratio
5.65%
Cash Position Ratio
5.3%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-102.96%
Return on assets
-95.84%
Return on sales
4686.78%
Return on invested capital
-32.56%
Total debt ratio
-109.24%
Debt ratio change over time
-1.09%
Current Ratio
-5.02%
Quick Ratio
-5.02%
Cash Position Ratio
-4.28%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SABS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -22.98% | 13.79% | 34.47% | 7.43% |
| Return on assets | -16.02% | 2.76% | 3.15% | 5.62% |
| Return on sales | -1933.56% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -50.59% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 38.65% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.09% | 308.97% | -6.99% | 1.18% |
| Dept financing | 11% | 50% | 25% | 7% |
| Current Ratio | 3.06% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 3.06% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.88% | 0.36% | 1.28% | 2.93% |
| Liquididy | 49% | 14% | 33% | 75% |
| Short-term ratios | SABS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -29.44% | 13.77% | 13.25% | 3.8% |
| Return on assets | -18.88% | 2.43% | 1.89% | 3.09% |
| Return on sales | -3846.8% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -67.1% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 37.07% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.12% | 46.38% | -72.08% | 1.51% |
| Dept financing | 10% | 50% | 25% | 7% |
| Current Ratio | 3.06% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 3.06% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.88% | 0.36% | 1.28% | 2.93% |
| Liquididy | 55% | 12% | 31% | 75% |